We are live on ! Find out more
NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

15 hedge funds and large institutions have $603K invested in Northwest Biotherapeutics, Inc. Common stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

15% more funds holding

Funds holding: 13 → 15 (+2)

5% more capital invested

Capital invested by funds: $576K → $603K (+$27K)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MSAM
Moloney Securities Asset Management
Missouri
+$32.3K
2
KA
Kovack Advisors
Florida
+$6K
3
BC
Bartlett & Co
Ohio
+$3K
4
BCWM
Bartlett & Co Wealth Management
Ohio
+$2.99K

Top Sellers

Rank Fund Capital Flow
1
AIP
Almanack Investment Partners
Pennsylvania
-$13.6K
2
CSWM
Cassady Schiller Wealth Management
Ohio
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
1
Ancora Advisors
Ohio
$262K – – –
MSAM
2
Moloney Securities Asset Management
Missouri
$194K +$32.3K +46,400 +20%
OCG
3
Opus Capital Group
Ohio
$31K – – –
WJWM
4
Williams Jones Wealth Management
New York
$27K – – –
GWI
5
Grace & White Inc
New York
$18K – – –
AIP
6
Almanack Investment Partners
Pennsylvania
$15K -$13.6K -20,000 -48%
LDB
7
Lee, Danner & Bass
Tennessee
$14K – – –
AA
8
AlphaMark Advisors
Kentucky
$10K – – –
GG
9
Gofen & Glossberg
Illinois
$9K – – –
ECM
10
Estabrook Capital Management
New York
$6.97K – – –
KA
11
Kovack Advisors
Florida
$6K +$6K +10,000 New
CAPTRUST Financial Advisors
12
CAPTRUST Financial Advisors
North Carolina
$4K – – –
BC
13
Bartlett & Co
Ohio
$3K +$3K +4,292 New
BCWM
14
Bartlett & Co Wealth Management
Ohio
$2.99K +$2.99K +4,292 New
CSWM
15
Cassady Schiller Wealth Management
Ohio
– -$1K -1,750 Closed

NWBO Hedge Fund Activity: Q1 2022 in Review

15 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics, Inc. Common stock (NWBO) for Q1 2022, worth a combined $603K — up 4.7% from $576K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NWBO positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Moloney Securities Asset Management, adding an estimated $32.3K. The largest seller was Almanack Investment Partners, cutting an estimated $13.6K.

  • 15 institutional investors held Northwest Biotherapeutics, Inc. Common stock (NWBO) as of Q1 2022, up from 13 in Q4 2021.
  • Funds reported $603K of Northwest Biotherapeutics, Inc. Common stock stock for Q1 2022, up 4.7% quarter-over-quarter.
  • 4 funds opened new Northwest Biotherapeutics, Inc. Common stock positions in Q1 2022 and 2 closed out, a net change of +2 holders.
  • The largest Northwest Biotherapeutics, Inc. Common stock buyer in Q1 2022 was Moloney Securities Asset Management, an estimated $32.3K added.
  • The largest Northwest Biotherapeutics, Inc. Common stock seller in Q1 2022 was Almanack Investment Partners, an estimated $13.6K sold.

Based on aggregated 13F filings for Q1 2022.